# S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

> **NCT00058448** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 1 (actual)

## Conditions studied

- Penile Cancer

## Interventions

- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00058448
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated due to poor patient recruitment.
- **Last updated:** 2018-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058448, "S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00058448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*